Launch public inquiry into excess deaths and vaccine harms
Reform UK · what the evidence says
An independent, source-checked look at Reform UK’s policy “Launch public inquiry into excess deaths and vaccine harms” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.
Healthcare — Little effect
minor · moderate confidence
A public inquiry investigates causes but does not directly treat patients, cut waiting lists, or add NHS capacity. Any healthcare improvements from its findings would be indirect and long-term at best.
The evidence
- The policy proposes launching a public inquiry into excess deaths and vaccine harms, asserting excess deaths are nearly as high as during the pandemic and young people are over-represented. — reformparty.uk (manifesto) — “Reform UK will launch a Public Inquiry into excess deaths and vaccine harms, noting that excess deaths are nearly as high as during the Covid pandemic and young people are over-represented.”
- Excess deaths have been a real and documented phenomenon, with over 28,000 (8.6%) more deaths than expected in the first six months of 2023. — pmc.ncbi.nlm.nih.gov (government) — “This trend continued into the first six months of 2023, with 28,024 (8.6%) more deaths than expected.”
- The claim that young people are over-represented in excess deaths is not clearly supported; proportional excess deaths were highest in the 75-79 age group, with the youngest groups representing small absolute numbers. — ons.gov.uk (government) — “the highest *proportional* excess deaths were in the 75-79 age group (21.3% increase, 8,935 excess deaths), while those aged 10-14 years had a 16.2% increase, representing a much smaller absolute number (31 excess deaths…”
- NHS pressures are a recognised contributor to excess deaths, with acute service strain leading to poorer outcomes. — pmc.ncbi.nlm.nih.gov (government) — “Acute pressures on NHS services, leading to poorer outcomes for acute illnesses and disruptions to chronic disease management.”
- The MHRA consistently concludes vaccine benefits outweigh risks of known adverse events. — pmc.ncbi.nlm.nih.gov (government) — “The MHRA consistently concludes that the benefits of COVID-19 vaccines in preventing infection and severe illness far outweigh the risks of known adverse events.”
- Existing monitoring of excess deaths is already ongoing through ONS and OHID. — gov.uk (media) — “The ONS and OHID continuously monitor excess deaths and their causes.”
- A UK COVID-19 public inquiry is already underway and addressing aspects of the pandemic response, making a further inquiry potentially redundant. — commonslibrary.parliament.uk (government) — “the UK COVID-19 public inquiry is already underway and addressing aspects of the pandemic response.”
- The IFS notes NHS is struggling to treat as many people as before the pandemic, suggesting underlying capacity problems an inquiry alone would not fix. — vertexaisearch.cloud.google.com (media) — “The IFS notes the NHS is struggling to treat as many people as before the pandemic.”
Biggest unknown: Whether inquiry findings would translate into actionable, implemented healthcare reforms — or simply duplicate existing monitoring and the ongoing COVID-19 public inquiry.
Our reading: A public inquiry is an investigative instrument, not a healthcare delivery mechanism. It produces findings and recommendations but does not itself increase NHS capacity, reduce waiting lists, improve GP access, or add hospital beds — the core indicators for O3. The excess deaths phenomenon is real and documented, but existing bodies (ONS, OHID) already monitor it continuously, and the ongoing COVID-19 public inquiry already covers pandemic response. The policy's framing that young people are 'over-represented' in excess deaths is contested by ONS data showing the 75-79 age group had the highest proportional excess, with young cohorts having very small absolute numbers. The vaccine-harm framing contradicts the MHRA's standing assessment that benefits outweigh risks. The most credible drivers of excess deaths identified in the evidence — NHS service pressure, cardiovascular disease, and socioeconomic factors — would not be addressed by an inquiry's existence. Any healthcare benefit would depend entirely on whether inquiry recommendations were implemented, which is speculative and long-term. The direction is therefore negligible for O3: the policy does not materially improve or worsen healthcare access and capacity on its own terms.
Equal treatment & democratic rights — Little effect
minor · low confidence
A public inquiry can be a legitimate tool of democratic accountability, but an existing UK COVID-19 public inquiry is already underway covering pandemic response, so the marginal addition to democratic rights and due process from a further inquiry is small. Whether it materially advances equal treatment or minority protections — O9's core indicators — is unclear.
The evidence
- The policy commits to launching a Public Inquiry specifically into excess deaths and vaccine harms, framing excess deaths as nearly as high as during the pandemic with young people over-represented. — reformparty.uk (manifesto) — “Reform UK will launch a Public Inquiry into excess deaths and vaccine harms, noting that excess deaths are nearly as high as during the Covid pandemic and young people are over-represented.”
- A UK COVID-19 public inquiry is already underway and the government has stated it has no plans for a further public inquiry into excess deaths, on the grounds the existing inquiry addresses aspects of the pandemic response. — commonslibrary.parliament.uk (government) — “the government has previously stated it has "no plans for a further public inquiry" into excess deaths, noting that the UK COVID-19 public inquiry is already underway and addressing aspects of the pandemic response.”
- The MHRA consistently concludes that the benefits of COVID-19 vaccines outweigh the risks of known adverse events, constituting existing regulatory due-process scrutiny of vaccine safety. — pmc.ncbi.nlm.nih.gov (government) — “The MHRA consistently concludes that the benefits of COVID-19 vaccines in preventing infection and severe illness far outweigh the risks of known adverse events.”
- The ONS and OHID continuously monitor excess deaths and their causes, representing ongoing institutional accountability. — gov.uk (media) — “The ONS and OHID continuously monitor excess deaths and their causes.”
Biggest unknown: Whether the scope of the proposed inquiry would cover ground genuinely not addressed by the existing UK COVID-19 public inquiry, and whether its framing of vaccine harms would be evidence-led or undermine public trust in regulatory due process.
Our reading: O9 concerns equal treatment, anti-discrimination, voting and democratic rights, due process, and minority protections. A public inquiry is a recognised instrument of democratic accountability and due process — so commissioning one is not irrelevant to O9. However, the marginal O9 effect of this specific policy is small. The existing UK COVID-19 public inquiry is already underway and already covers pandemic response; the government has explicitly noted this as its rationale for no further inquiry. MHRA and ONS/OHID already conduct ongoing regulatory and statistical scrutiny of vaccine safety and excess deaths. The policy therefore adds a layer of formal democratic scrutiny in a space where scrutiny already exists, rather than opening a gap that currently has none. The policy framing — asserting that excess deaths remain near pandemic highs and that young people are over-represented — is contested by the evidence (ONS methodology updates, age-group data showing older cohorts are proportionally most affected), but this bears on the policy's factual premise, not directly on its O9 effect. The policy's concrete commitment (an actual inquiry, not just a review or exploration) earns it a 'stated' instrument. But the incremental gain to due process and democratic rights, given existing mechanisms, is minor at most. There is no clear equal-treatment or minority-protection dimension. Overall: negligible to minor improvement in democratic accountability, with low confidence given overlap with existing inquiry scope.